Surgery Doctors in Waxahachie, TX Accepting Medicare

7 Surgery doctors found. Showing 1 - 7

Dr. Watson Payne Roye Jr., M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1305 W Jefferson St, Suite 120, Waxahachie, TX 75165 Phone: 972-923-1457    Fax: 972-923-1304

William Charles Major, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1626 W Hwy 287 Business, Suite 101, Waxahachie, TX 75165 Phone: 972-937-6902    Fax: 972-937-4172

Gary Peter Graham, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1305 W Jefferson St Ste 120, Waxahachie, TX 75165 Phone: 972-923-1457

Valerie Jean Gorman, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1505 W Jefferson St, Suite 165, Waxahachie, TX 75165 Phone: 972-923-1457    Fax: 972-923-1304

Dr. Elizabeth Costa Hamilton, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2460 N Ih 35 E Ste 160, Waxahachie, TX 75165 Phone: 469-800-9830    Fax: 469-800-9840

Nathan Andrew Ludwig, Surgery Medicare: Accepting Medicare Assignments Practice Location: 2460 N Ih 35 E Ste 215, Waxahachie, TX 75165 Phone: 469-800-9830

Dr. Mazen Iskandar, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2460 N I 35 Ste 215, Waxahachie, TX 75165 Phone: 469-800-9830

News Archive

Training can change adult brain's structure

As London taxi drivers in training are busy learning how to navigate the city's thousands of streets and places of interest over a period of years, the experience actually changes the very structure of their brains, according to a report published online on December 8 in Current Biology, a Cell Press publication.

Moderates against government-run 'public option'

Moderates from both parties backed away from a government-run public health insurance option Sunday, as they appeared on various Sunday talk shows.

Alnylam reports pre-clinical data from ALN-AS1 program for treatment of AIP

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented key pre-clinical proof-of-concept data from its RNAi therapeutic program targeting aminolevulinate synthase-1 (ALAS-1) for the treatment of porphyria including acute intermittent porphyria.

Bioxodes completes seed funding round to bring Ir-CPI product into pre-clinical development

Bioxodes SA, a company developing products derived from natural sources, has completed a EUR 2.6 million (USD 3.5 million) first seed funding round with a consortium of business angels and Belgian investment funds. EUR 1.6 million is from the European Regional Development Fund and the Walloon Region in Belgium via the Retech program for Research and Technology. It will be used to bring the company's lead product Ir-CPI into pre-clinical development over the next 18 months.

Widespread misinformation about Obama's healthcare proposals

A new Harris Poll finds that large numbers of people either believe damaging misinformation about the health care proposals being discussed in Washington or are not sure what to believe. The polls also shows that almost half of all adults continue to support what they see as President Obama's health care reform proposals, significantly but not substantially more than oppose them.

Read more Medical News

› Verified 2 days ago